Showing results (71-80 of 1,561) with videos related to
Sort By:
Pageof 157
American Journal of Hematology|May 1, 1990
"Idiopathic thrombocytopenic purpura-like syndrome" treated with interferon in a patient with lung cancerB L Rapoport, G Falkson, A S Alberts, et al.American Journal of Clinical Oncology|August 1, 1995
Hepatocellular carcinoma. An ECOG randomized phase II study of beta-interferon and menogarilG Falkson, S Lipsitz, E Borden, et al.Cancer Treatment Reports|February 1, 1979
Acute leukemia as a complication of long-term treatment of advanced breast cancerM A Portugal, H C Falkson, K Stevens, et al.Cancer|February 15, 1986
Hepatitis-B as a prognostic discriminant in patients with primary liver cancerG Falkson, R H Böhmer, M Adam, et al.Tumori|October 31, 1990
A phase II study of idarubicin and prednisone in multiple myelomaA S Alberts, G Falkson, B L Rapoport, et al.Cancer Clinical Trials|January 1, 1981
Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancerY C Chang, G Falkson, D C Tormey, et al.Cancer Treatment Reports|August 1, 1982
Combined doxorubicin and radiation therapy in malignant pleural mesotheliomaC Sinoff, G Falkson, A G Sandison, et al.American Journal of Clinical Oncology|February 1, 1992
A phase II study of 5-fluorouracil and leucovorin in advanced carcinoma of the esophagusA S Alberts, L Schoeman, W Burger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group studyG Falkson, R Gelman, C I Falkson, et al.Oncology|January 1, 1992
Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancerC I Falkson, G Falkson, C B Falkson, et al.Pageof 157